{
 "drug": "Hydrocortisone Sodium Succinate Injection",
 "asOf": "2026-08-25",
 "status": "resolved",
 "since": "03/24/2023",
 "dayN": 1250,
 "cat": "Pulmonary/Allergy",
 "companies": [
  "Hospira, Inc., a Pfizer Company",
  "Cipla Limited"
 ],
 "reasons": [],
 "records": [
  {
   "update_type": "Revised",
   "initial_posting_date": "03/24/2023",
   "change_date": "02/24/2026",
   "package_ndc": "0009-0013-05",
   "generic_name": "Hydrocortisone Sodium Succinate Injection",
   "contact_info": "844-646-4398",
   "resolved_note": "Available",
   "openfda": {
    "application_number": [
     "NDA009866"
    ],
    "brand_name": [
     "SOLU-CORTEF"
    ],
    "generic_name": [
     "HYDROCORTISONE SODIUM SUCCINATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-0013",
     "0009-0825",
     "0009-0011",
     "0009-0016",
     "0009-0005"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "HYDROCORTISONE SODIUM SUCCINATE"
    ],
    "rxcui": [
     "105398",
     "238755",
     "1738586",
     "1738589",
     "1738590",
     "1738592",
     "1738594",
     "1738596"
    ],
    "spl_id": [
     "8512044a-4a54-4634-bb97-9e20126adc61"
    ],
    "spl_set_id": [
     "65eefd58-b166-4d71-ade6-45c8fdf86922"
    ],
    "package_ndc": [
     "0009-0825-01",
     "0009-0011-03",
     "0009-0011-04",
     "0009-0013-05",
     "0009-0013-06",
     "0009-0016-12",
     "0009-0005-01"
    ],
    "unii": [
     "50LQB69S1Z"
    ]
   },
   "update_date": "02/24/2026",
   "therapeutic_category": [
    "Pulmonary/Allergy",
    "Dermatology",
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Hematology",
    "Neurology",
    "Oncology",
    "Ophthalmology",
    "Pediatric",
    "Renal",
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Solu-cortef, Injection, 250 mg/vial (NDC 0009-0013-05)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Resolved"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "03/24/2023",
   "change_date": "02/24/2026",
   "package_ndc": "0009-0013-06",
   "generic_name": "Hydrocortisone Sodium Succinate Injection",
   "contact_info": "844-646-4398",
   "resolved_note": "Available",
   "openfda": {
    "application_number": [
     "NDA009866"
    ],
    "brand_name": [
     "SOLU-CORTEF"
    ],
    "generic_name": [
     "HYDROCORTISONE SODIUM SUCCINATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-0013",
     "0009-0825",
     "0009-0011",
     "0009-0016",
     "0009-0005"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "HYDROCORTISONE SODIUM SUCCINATE"
    ],
    "rxcui": [
     "105398",
     "238755",
     "1738586",
     "1738589",
     "1738590",
     "1738592",
     "1738594",
     "1738596"
    ],
    "spl_id": [
     "8512044a-4a54-4634-bb97-9e20126adc61"
    ],
    "spl_set_id": [
     "65eefd58-b166-4d71-ade6-45c8fdf86922"
    ],
    "package_ndc": [
     "0009-0825-01",
     "0009-0011-03",
     "0009-0011-04",
     "0009-0013-05",
     "0009-0013-06",
     "0009-0016-12",
     "0009-0005-01"
    ],
    "unii": [
     "50LQB69S1Z"
    ]
   },
   "update_date": "02/24/2026",
   "therapeutic_category": [
    "Pulmonary/Allergy",
    "Dermatology",
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Hematology",
    "Neurology",
    "Oncology",
    "Ophthalmology",
    "Pediatric",
    "Renal",
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Solu-cortef, Injection, 250 mg/vial (NDC 0009-0013-06)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Resolved"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "03/24/2023",
   "change_date": "02/24/2026",
   "package_ndc": "69097-004-67",
   "generic_name": "Hydrocortisone Sodium Succinate Injection",
   "contact_info": "844-247-5287",
   "resolved_note": "Available",
   "openfda": {
    "application_number": [
     "ANDA214050"
    ],
    "brand_name": [
     "HYDROCORTISONE SODIUM SUCCINATE"
    ],
    "generic_name": [
     "HYDROCORTISONE SODIUM SUCCINATE"
    ],
    "manufacturer_name": [
     "Cipla USA Inc."
    ],
    "product_ndc": [
     "69097-004"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "HYDROCORTISONE SODIUM SUCCINATE"
    ],
    "rxcui": [
     "238755"
    ],
    "spl_id": [
     "44159bea-88a1-49ac-a51e-1c27dc89d9ff"
    ],
    "spl_set_id": [
     "451d6d04-b7d9-47d9-ba71-43cc5b9b3054"
    ],
    "package_ndc": [
     "69097-004-67"
    ],
    "unii": [
     "50LQB69S1Z"
    ]
   },
   "update_date": "02/24/2026",
   "therapeutic_category": [
    "Dermatology",
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Hematology",
    "Neurology",
    "Oncology",
    "Ophthalmology",
    "Pediatric",
    "Pulmonary/Allergy",
    "Renal",
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Hydrocortisone Sodium Succinate, Injection, 100 mg/ Vial (NDC 69097-004-67)",
   "company_name": "Cipla Limited",
   "status": "Resolved"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "03/24/2023",
   "change_date": "02/24/2026",
   "package_ndc": "0009-0016-12",
   "generic_name": "Hydrocortisone Sodium Succinate Injection",
   "contact_info": "844-646-4398",
   "resolved_note": "Available",
   "openfda": {
    "application_number": [
     "NDA009866"
    ],
    "brand_name": [
     "SOLU-CORTEF"
    ],
    "generic_name": [
     "HYDROCORTISONE SODIUM SUCCINATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-0016",
     "0009-0825",
     "0009-0011",
     "0009-0013",
     "0009-0005"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "HYDROCORTISONE SODIUM SUCCINATE"
    ],
    "rxcui": [
     "105398",
     "238755",
     "1738586",
     "1738589",
     "1738590",
     "1738592",
     "1738594",
     "1738596"
    ],
    "spl_id": [
     "8512044a-4a54-4634-bb97-9e20126adc61"
    ],
    "spl_set_id": [
     "65eefd58-b166-4d71-ade6-45c8fdf86922"
    ],
    "package_ndc": [
     "0009-0825-01",
     "0009-0011-03",
     "0009-0011-04",
     "0009-0013-05",
     "0009-0013-06",
     "0009-0016-12",
     "0009-0005-01"
    ],
    "unii": [
     "50LQB69S1Z"
    ]
   },
   "update_date": "02/24/2026",
   "therapeutic_category": [
    "Pulmonary/Allergy",
    "Dermatology",
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Hematology",
    "Neurology",
    "Oncology",
    "Ophthalmology",
    "Pediatric",
    "Renal",
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Solu-cortef, Injection, 500 mg/vial (NDC 0009-0016-12)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Resolved"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "03/24/2023",
   "change_date": "02/24/2026",
   "package_ndc": "0009-0825-01",
   "generic_name": "Hydrocortisone Sodium Succinate Injection",
   "contact_info": "844-646-4398",
   "resolved_note": "Available",
   "openfda": {
    "application_number": [
     "NDA009866"
    ],
    "brand_name": [
     "SOLU-CORTEF"
    ],
    "generic_name": [
     "HYDROCORTISONE SODIUM SUCCINATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-0825",
     "0009-0011",
     "0009-0013",
     "0009-0016",
     "0009-0005"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "HYDROCORTISONE SODIUM SUCCINATE"
    ],
    "rxcui": [
     "105398",
     "238755",
     "1738586",
     "1738589",
     "1738590",
     "1738592",
     "1738594",
     "1738596"
    ],
    "spl_id": [
     "8512044a-4a54-4634-bb97-9e20126adc61"
    ],
    "spl_set_id": [
     "65eefd58-b166-4d71-ade6-45c8fdf86922"
    ],
    "package_ndc": [
     "0009-0825-01",
     "0009-0011-03",
     "0009-0011-04",
     "0009-0013-05",
     "0009-0013-06",
     "0009-0016-12",
     "0009-0005-01"
    ],
    "unii": [
     "50LQB69S1Z"
    ]
   },
   "update_date": "02/24/2026",
   "therapeutic_category": [
    "Pulmonary/Allergy",
    "Dermatology",
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Hematology",
    "Neurology",
    "Oncology",
    "Ophthalmology",
    "Pediatric",
    "Renal",
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Solu-cortef, Injection, 100 mg/vial (NDC 0009-0825-01)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Resolved"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "03/24/2023",
   "change_date": "02/24/2026",
   "package_ndc": "0009-0011-04",
   "generic_name": "Hydrocortisone Sodium Succinate Injection",
   "contact_info": "844-646-4398",
   "resolved_note": "Available",
   "openfda": {
    "application_number": [
     "NDA009866"
    ],
    "brand_name": [
     "SOLU-CORTEF"
    ],
    "generic_name": [
     "HYDROCORTISONE SODIUM SUCCINATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-0011",
     "0009-0825",
     "0009-0013",
     "0009-0016",
     "0009-0005"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "HYDROCORTISONE SODIUM SUCCINATE"
    ],
    "rxcui": [
     "105398",
     "238755",
     "1738586",
     "1738589",
     "1738590",
     "1738592",
     "1738594",
     "1738596"
    ],
    "spl_id": [
     "8512044a-4a54-4634-bb97-9e20126adc61"
    ],
    "spl_set_id": [
     "65eefd58-b166-4d71-ade6-45c8fdf86922"
    ],
    "package_ndc": [
     "0009-0825-01",
     "0009-0011-03",
     "0009-0011-04",
     "0009-0013-05",
     "0009-0013-06",
     "0009-0016-12",
     "0009-0005-01"
    ],
    "unii": [
     "50LQB69S1Z"
    ]
   },
   "update_date": "02/24/2026",
   "therapeutic_category": [
    "Pulmonary/Allergy",
    "Dermatology",
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Hematology",
    "Neurology",
    "Oncology",
    "Ophthalmology",
    "Pediatric",
    "Renal",
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Solu-cortef, Injection, 100 mg/vial (NDC 0009-0011-04)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Resolved"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "03/24/2023",
   "change_date": "02/24/2026",
   "package_ndc": "0009-0005-01",
   "generic_name": "Hydrocortisone Sodium Succinate Injection",
   "contact_info": "844-646-4398",
   "resolved_note": "Available",
   "openfda": {
    "application_number": [
     "NDA009866"
    ],
    "brand_name": [
     "SOLU-CORTEF"
    ],
    "generic_name": [
     "HYDROCORTISONE SODIUM SUCCINATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-0005",
     "0009-0825",
     "0009-0011",
     "0009-0013",
     "0009-0016"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "HYDROCORTISONE SODIUM SUCCINATE"
    ],
    "rxcui": [
     "105398",
     "238755",
     "1738586",
     "1738589",
     "1738590",
     "1738592",
     "1738594",
     "1738596"
    ],
    "spl_id": [
     "8512044a-4a54-4634-bb97-9e20126adc61"
    ],
    "spl_set_id": [
     "65eefd58-b166-4d71-ade6-45c8fdf86922"
    ],
    "package_ndc": [
     "0009-0825-01",
     "0009-0011-03",
     "0009-0011-04",
     "0009-0013-05",
     "0009-0013-06",
     "0009-0016-12",
     "0009-0005-01"
    ],
    "unii": [
     "50LQB69S1Z"
    ]
   },
   "update_date": "02/24/2026",
   "therapeutic_category": [
    "Pulmonary/Allergy",
    "Dermatology",
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Hematology",
    "Neurology",
    "Oncology",
    "Ophthalmology",
    "Pediatric",
    "Renal",
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Solu-cortef, Injection, 1000 mg/vial (NDC 0009-0005-01)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Resolved"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "03/24/2023",
   "change_date": "02/24/2026",
   "package_ndc": "0009-0011-03",
   "generic_name": "Hydrocortisone Sodium Succinate Injection",
   "contact_info": "844-646-4398",
   "resolved_note": "Available",
   "openfda": {
    "application_number": [
     "NDA009866"
    ],
    "brand_name": [
     "SOLU-CORTEF"
    ],
    "generic_name": [
     "HYDROCORTISONE SODIUM SUCCINATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-0011",
     "0009-0825",
     "0009-0013",
     "0009-0016",
     "0009-0005"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "HYDROCORTISONE SODIUM SUCCINATE"
    ],
    "rxcui": [
     "105398",
     "238755",
     "1738586",
     "1738589",
     "1738590",
     "1738592",
     "1738594",
     "1738596"
    ],
    "spl_id": [
     "8512044a-4a54-4634-bb97-9e20126adc61"
    ],
    "spl_set_id": [
     "65eefd58-b166-4d71-ade6-45c8fdf86922"
    ],
    "package_ndc": [
     "0009-0825-01",
     "0009-0011-03",
     "0009-0011-04",
     "0009-0013-05",
     "0009-0013-06",
     "0009-0016-12",
     "0009-0005-01"
    ],
    "unii": [
     "50LQB69S1Z"
    ]
   },
   "update_date": "02/24/2026",
   "therapeutic_category": [
    "Pulmonary/Allergy",
    "Dermatology",
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Hematology",
    "Neurology",
    "Oncology",
    "Ophthalmology",
    "Pediatric",
    "Renal",
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Solu-Cortef, Injection, 100 mg/vial (NDC 0009-0011-03)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Resolved"
  }
 ]
}